Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of value gouging, mentioning the stark distinction in between U.S. selling prices and those in Europe and copyright.Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[